F Spyratos

ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma.

I. Bièche, M. Vidaud, S. Tozlu, 2001, Cancer letters.

Prognostic value of histologic grade nuclear components of Scarff‐Bloom‐Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas

S Friedman, M Brunet, S. Friedman, 1989, Cancer.

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

F. Spyratos, J. Seigneurin, M. Buisson, 2001, British Journal of Cancer.

CCND1 mRNA Overexpression is Highly Related to Estrogen Receptor Positivity but not to Proliferative Markers in Primary Breast Cancer

I. Bièche, M. Vidaud, R. Lidereau, 2000, The International journal of biological markers.

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

S. Vacher, I. Bièche, S. Tozlu, 2006, Endocrine-related cancer.

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

B Asselain, P Broët, B. Asselain, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.